As regards other potential traceable biomarkers, it is important to mention that the dysregulation in microRNA (miRNA) biogenesis and metabolism can result from reduced levels of SMN protein in SMA patients. This evidence concerns the gene SMN1 and proximal spinal muscular atrophy.